SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-083564
Filing Date
2023-07-24
Accepted
2023-07-24 21:05:23
Documents
2
Period of Report
2023-07-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2321918-7_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2321918-7_3seq1.xml 3 1560
2 EXHIBIT 24 tm2321918d7_ex-24.htm EX-24 11015
  Complete submission text file 0001104659-23-083564.txt   14080
Mailing Address C/O AEON BIOPHARMA, INC. 4040 MACARTHUR BOULEVARD, SUITE 250 NEWPORT BEACH CA 92660
Business Address
FISCHER JOST (Reporting) CIK: 0001366841 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40021 | Film No.: 231106258

Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Issuer) CIK: 0001837607 (see all company filings)

IRS No.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations